The Russian coronavirus vaccine Sputnik V has shown equal efficacy in all age categories. This was announced by the head of the Gamaleya centre, Alexander Gintsburg, on Saturday, March 13
“There were initially doubts that the efficacy on people aged 60+ might be less. Due to the fact that the immune system is no longer responding as well, will respond worse to vaccination – nothing like that”, – he said.
According to Gintsburg, the duration of the drug could be more than two years. It is predicted that 70% of the country’s population will be vaccinated against COVID-19 by November, he added.Bloomberg: EU ambassador to Russia suggests new strategy for relations with Russia